Lupin receives USFDA EIR for Goa facility with VAI status

Lupin receives USFDA EIR for Goa facility with VAI status

Drug maker Lupin said it has received an Establishment Inspection Report from the US Food and Drug Administration for its Goa-based manufacturing facility, with a Voluntary Action Indicated classification following a November 2025 inspection.

New Delhi: Drug maker Lupin on Friday said it has received an Establishment Inspection Report (EIR) from the US health regulator for its Goa-based manufacturing facility.The company said it has recei… [+648 chars]